Logo

Warner Bros’ “Final Destination: Bloodlines” pulled in an impressive $21 million in its debut Friday, on its way to what is projected to be a record-breaking opening weekend.

Insiders predict the horror flick will breeze past the franchise’s best opening weekend to date, which brought in $41.3 million adjusted for inflation for 2009’s “Final Destination 4.”


  “Bloodlines” star Kaitlyn Santa Juana plays a college student who inherits deadly premonitions about her family. Warner Bros. “Bloodlines” star Kaitlyn Santa Juana plays a college student who inherits deadly premonitions about her family. Warner Bros.

  “Sinners” stars Jordan in dual roles as criminal twin brothers. ©Warner Bros/Courtesy Everett Collection “Sinners” stars Jordan in dual roles as criminal twin brothers. ©Warner Bros/Courtesy Everett Collection

The movie is expected to put an end to “Thunderbolts*” reign at the top of the box office charts.

The Marvel movie continued to hold the No. 1 spot this week, raking in $43 million in the US, according to industry website The Numbers.


  “Thunderbolts*” follows an unconventional team of antiheroes on a mission that forces them to confront their dark pasts. ©Walt Disney Co./Courtesy Everett Collection “Thunderbolts*” follows an unconventional team of antiheroes on a mission that forces them to confront their dark pasts. ©Walt Disney Co./Courtesy Everett Collection

“Thunderbolts*” grossed $143 million in domestic sales since it theater debuted on May 2 — and totaled $286 million across the globe.


  “Thunderbolts*” is the latest Marvel movie. IMDB “Thunderbolts*” is the latest Marvel movie. IMDB

Meanwhile “Sinners,” the musical horror film starring Michael B. Jordan, earned the second spot, earning $32 million this week.

The movie, set in the Mississippi Delta in 1932, has earned $229 million since its debut on April 17.

Comments
anonymous profile image
Powered by RoundtableBuilt on infrastructure designed for real-time media. Learn more at RTB.io.© Roundtable 2026. By using this site you agree to the Terms of Use and Privacy Policy